{
    "200_day_moving_avg": {
        "title": "200-Day Moving Average",
        "value": "4.3748"
    },
    "50_day_moving_avg": {
        "title": "50-Day Moving Average",
        "value": "4.5494"
    },
    "52_week_change": {
        "title": "52-Week Change",
        "value": "-48.31%"
    },
    "52_week_high": {
        "title": "52 Week High",
        "value": "12.9500"
    },
    "52_week_low": {
        "title": "52 Week Low",
        "value": "2.9600"
    },
    "company_name": {
        "title": "Company Name",
        "value": "BriaCell Therapeutics Corp. (BCTX)"
    },
    "float": {
        "title": "Float",
        "value": "3.42M"
    },
    "fullTimeEmployees": {
        "title": "Profile",
        "value": null
    },
    "held_by_insiders": {
        "title": "% Held by Insiders",
        "value": "23.16%"
    },
    "held_by_institutions": {
        "title": "% Held by Institutions",
        "value": "36.29%"
    },
    "industry": {
        "title": "Industry",
        "value": "Biotechnology"
    },
    "profile": {
        "title": "Profile",
        "value": "BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada."
    },
    "sector": {
        "title": "Sector",
        "value": "Healthcare"
    },
    "shares_outstanding": {
        "title": "Shares Outstanding",
        "value": "5.62M"
    },
    "shares_short": {
        "title": "Shares Short (Mar 15, 2021)",
        "value": "36.17k"
    },
    "short_percent_of_float": {
        "title": "Short % of Float (Mar 15, 2021)",
        "value": "N/A"
    },
    "short_percent_of_shares_outstanding": {
        "title": "Short % of Shares Outstanding (Mar 15, 2021)",
        "value": "0.64%"
    },
    "short_ratio": {
        "title": "Short Ratio (Mar 15, 2021)",
        "value": "0.04"
    }
}